Expert Pitch
University of California, Los Angeles (UCLA), Health Sciences

UCLA Fielding School of Public Health faculty experts available for media covering novel coronavirus (COVID-19)

Newswise — UCLA Fielding School of Public Health experts available for media covering novel coronavirus (COVID-19) include:

Dr. Robert J. Kim-Farley serves as professor-in-residence of epidemiology and community health sciences at the Fielding School. His previous roles include director of the Division of Communicable Disease Control and Prevention at the Los Angeles County Department of Public Health, and service with the U.S. Centers for Disease Control and Prevention, and the World Health Organization in Indonesia, India, and Switzerland. Kim-Farley addresses public health preparedness for, and response to, deliberate use of biological agents, and reduction and eradication of communicable diseases. Recently quoted by The Guardian, Los Angeles Times, and National Public Radio.

Anne Rimoin, a professor of epidemiology at the Fielding School, is an expert in emerging infectious diseases, ebolavirus, zoonoses, immunization, and infectious disease epidemiology. Rimoin is the founder of the UCLA-DRC Health Research and Training Program in the Democratic Republic of the Congo and serves as director of the Center for Global and Immigrant Health at the Fielding School. Recently quoted by the BBC News, Forbes, Fox Business, and USA Today.

Gilbert Gee is a professor of community health sciences at the Fielding School. A primary line of his research focuses on conceptualizing and measuring racial discrimination, and in understanding how discrimination may be related to illness. His work on health surveys and disease exposure has been recognized by the (U.S.) National Institutes of Health and the Environmental Protection Agency. Recently quoted in PBS: Christiane Amanpour & Co., the Los Angeles Times, Fort Worth Star-Telegram, and Seattle Times.

Dr. Zuo-Feng Zhang is the associate dean for research and a professor of epidemiology at the Fielding School. Zhang’s service includes his tenure as WHO Consultant for National Noncommunicable Disease Prevention and Controls in China, and as a regular member of NIH Epidemiology of Cancer Study Section. Recently quoted by Xinhua, China Philanthropist, and The Intellectual.

Dr. Timothy Brewer, professor of epidemiology at the Fielding School, has served on advisory boards and review panels for international and national organizations including the World Health Organization, the National Institutes of Health, the US Centers for Disease Control and Prevention, and the Canadian Institutes of Health Research, among others, and currently serves as the Chair of the Board of Directors for the Consortium of Universities for Global Health. Recently quoted in the New York Times and Los Angeles Times.

Dr. David Eisenman, is director of the Center for Public Health and Disasters and professor-in-residence of community health sciences at the Fielding School. Eisenman’s work addresses community resilience, mental health in primary care, trauma, climate change, and violence prevention. Recently quoted in the New York Times.

Dr. Jeffrey Klausner is an adjunct professor of epidemiology at the Fielding School whose research interests are in applied epidemiology and the prevention and control of infectious diseases of public health importance like HIV, STDs, TB and Cryptococcus. Klausner previously served with the San Francisco County Department of Public Health and the U.S. Centers for Disease Control and Prevention. Recently quoted in the Los Angeles Times and by Fox News Los Angeles.

On Feb. 10, the Fielding School hosted a symposium on COVID-19 titled “What do we know and what’s next?” Speakers included faculty from the UCLA Fielding School of Public Health, the David Geffen School of Medicine at UCLA, the UCLA School of Law, and  the UCLA Center for Chinese Studies. A video of the event is NOVEL CORONAVIRUS: WHAT DO WE KNOW AND WHAT’S NEXT?:




Filters close

Showing results

110 of 4148
access_time Embargo lifts in 2 days
Embargo will expire: 1-Dec-2020 11:00 AM EST Released to reporters: 30-Nov-2020 8:40 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2020 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: COVID-19 Peer Hub combats vaccine avoidance amid pandemic
Released: 27-Nov-2020 8:05 AM EST
COVID-19 Peer Hub combats vaccine avoidance amid pandemic
University of South Australia

UniSA researchers are evaluating a new vaccination education initiative – the COVID-19 Peer Hub – to help immunisation and public health professionals to tackle the emerging dangers of vaccine hesitancy amid the pandemic.

Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.


Showing results

110 of 4148

close
1.53228